|Articles|January 24, 2022
This week on Contemporary OB/GYN®: Jan. 24 to Jan. 28
Author(s)Lindsey Carr, Editor
A look at what's coming to Contemporary OB/GYN® this week.
Advertisement
The effect of eating disorders in pregnancy on neurodevelopmental risk in infants
Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.
Pembrolizumab plus lenvatinib show promise in advanced endometrial carcinoma
The latest trial results showed statistically significant improvements in overall survival and progression-free survival.
Agile Therapeutics partners with Afayxs to expand access to Twirla®
Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla®) transdermal system.
Check back soon for additional updates.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI
2
Individualized TRT demonstrates broad symptom improvements beyond sexual function
3
Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds
4
Acetaminophen remains first-line medication for pain, fever in pregnancy, SMFM says
5